Bioxytran publishes positive peer-reviewed data for ProLectin-M and PLG-007 drug candidates

BIOXYTRAN, INC

August 1, 2022 article in Int. J. Health Sciences: ProLectin-M blocks SARS-CoV-2 in vitro; all 5 COVID-19 patients achieved complete remission, zero hospitalization.
July 13, 2022 article in Int. J. Molecular Science: PLG-007 component GMα competitively inhibits α-amylase, maltase, and lactase with Ki of 2.1×10^-6M.
Press release issued August 1, 2022 announcing the ProLectin-M peer-reviewed article and supporting mechanism of action data.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.